In this study, treatment with cisplatin or taxol increased EREG expression through the ERK1/2 phosphorylation in NSCLC cells, whereas EREG stimulation enhanced the viability of taxol-treated NSCLC cells with the elevated expression of stemness-associated genes, such as Nanog and Sox2. This evidence concerns the gene SOX2 and non-small cell lung carcinoma.